Predictive ability of DNA microarrays for cancer outcomes and correlates: An empirical assessment

Lancet

Volumn 362, Issue 9394, 2003, Pages 1439-1444

  Ntzani, Evangelia E ^a   Ioannidis, John P A ^a,b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CYTODIAGNOSIS; CANCER GROWTH; CANCER MODEL; CANCER MORTALITY; CANCER RECURRENCE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DNA MICROARRAY; GENE EXPRESSION PROFILING; INFORMATION RETRIEVAL; MEDICAL ASSESSMENT; MEDLINE; PREDICTION; PRIORITY JOURNAL; SAMPLE SIZE; TREATMENT OUTCOME;

EID: 0242361278     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14686-7     Document Type: Article

References (21)

1. Lander E.S. Array of hope. Nat Genet. 21:(suppl 1):1999;3-4.
2. Duggan D.J., Bittner M., Chen Y., Meltzer P., Trent J.M. Expression profiling using cDNA microarrays. Nat Genet. 21:(suppl 1):1999;10-14.
3. Aitman T.J. DNA microarrays in medical practice. BMJ. 323:2001;611-615.
4. Chung C.H., Bernard P.S., Perou C.M. Molecular portraits and the family tree of cancer. Nat Genet. 32:(suppl 2):2002;533-540.
5. Schumacher M., Hollander N., Sauerbrei W. Resampling and cross-validation techniques: a tool to reduce bias caused by model building? Stat Med. 16:1997;2813-2827.
6. Altman D.G., Royston P. What do we mean by validating a prognostic model? Stat Med. 19:2000;453-473.
7. Simon R., Radmacher M.D., Dobbin K., McShane L.M. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. J Natl Cancer Inst. 95:2003;14-18.
8. Ioannidis J.P., Trikalinos T.A., Ntzani E.E., Contopoulos-Ioannidis D.G. Genetic associations in large versus smaller studies: an empirical assessment. Lancet. 361:2003;567-571.
9. Ioannidis J.P., Ntzani E.E., Trikalinos T.A., Contopoulos-Ioannidis D.G. Replication validity of genetic association studies. Nat Genet. 29:2001;206-209.
10. Sterne J.A., Egger M., Smith G.D. Systematic reviews in health care: investigating and dealing with publication and other biases in meta-analysis. BMJ. 323:2001;101-105.
11. Simon R., Altman D.G. Statistical aspects of prognostic factor studies in oncology. Br J Cancer. 69:1994;979-985.
12. Bogardus S.T. Jr, Concato J., Feinstein A.R. Clinical epidemiological quality in molecular genetic research: the need for methodological standards. JAMA. 281:1999;1919-1926.
13. Petricoin E.F. III, Hackett J.L., Lesko L.J., et al. Medical applications of microarray technologies: a regulatory science perspective. Nat Genet. 32:(suppl 2):2002;474-479.
14. Golub T.R. Genome-wide views of cancer. N Engl J Med. 344:2001;601-602.
15. King H.C., Sinha A.A. Gene expression profile analysis by DNA microarrays: promise and pitfalls. JAMA. 286:2001;2280-2288.
16. Firestein G.S., Pisetsky D.S. DNA microarrays: boundless technology or bound by technology? Guidelines for studies using microarray technology. Arthritis Rheum. 46:2002;859-861.
17. Wittes J., Friedman H.P. Searching for evidence of altered gene expression: a comment on statistical analysis of microarray data. J Natl Cancer Inst. 91:1999;400-401.
18. Churchill G.A. Fundamentals of experimental design for cDNA microarrays. Nat Genet. 32:(suppl 2):2002;490-495.
19. Stoeckert C.J., Causton H.C., Ball C.A. Microarray databases: standards and ontologies. Nat Genet. 32:(suppl 2):2002;469-473.
20. Brazma A., Hingamp P., Quackenbush J., et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet. 29:2001;365-371.
21. Contopoulos-Ioannidis D.G., Ntzani E., Ioannidis J.P. Time to translation of promising basic science research to clinical applications. Am J Med. 114:2003;477-484.